Minimal Hepatic Encephalopathy: Clinical Trials

2 trials for Minimal Hepatic Encephalopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Minimal Hepatic Encephalopathy: new trials by email Literature Review of Minimal Hepatic Encephalopathy trials Research Report on Minimal Hepatic Encephalopathy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Rifaximin in Minimal Hepatic Encephalopathy
Rifaximin, rifaximin - Minimal Hepatic Encephalopathy
Phase 1 / Phase 2CompletedHunter Holmes Mcguire Veteran Affairs Medical Center202010-02-012012-12-11
Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy
Lactobacillus GG, Placebo - Minimal Hepatic Encephalopathy
Phase 1CompletedVirginia Commonwealth University372009-10-012014-01-07

Narrower conditions

Fibrosis (2)  ·  Hepatic Encephalopathy (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Central Nervous System Diseases (1)  ·  Digestive System Diseases (1)  ·  Hepatic Insufficiency (1)  ·  Liver Diseases (1)  ·  Liver Failure (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Rifaximin (1)

Sponsors

Hunter Holmes Mcguire Veteran Affairs Medical Center (1)  ·  Virginia Commonwealth University (1)

Countries

United States (2)

Top investigators

Jasmohan S Bajaj, MD, MSc (2)

Results publications

PMID 23565181

NIH funding

U01AT004428 (1)